| Product Code: ETC13146244 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Hereditary Cancer Testing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Hereditary Cancer Testing Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Hereditary Cancer Testing Market Revenues & Volume, 2021 & 2031F |
3.3 North America Hereditary Cancer Testing Market - Industry Life Cycle |
3.4 North America Hereditary Cancer Testing Market - Porter's Five Forces |
3.5 North America Hereditary Cancer Testing Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Hereditary Cancer Testing Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.7 North America Hereditary Cancer Testing Market Revenues & Volume Share, By Diagnosis Type, 2021 & 2031F |
3.8 North America Hereditary Cancer Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 North America Hereditary Cancer Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 North America Hereditary Cancer Testing Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 North America Hereditary Cancer Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Hereditary Cancer Testing Market Trends |
6 North America Hereditary Cancer Testing Market, 2021 - 2031 |
6.1 North America Hereditary Cancer Testing Market, Revenues & Volume, By Test Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Hereditary Cancer Testing Market, Revenues & Volume, By Multi Panel Set, 2021 - 2031 |
6.1.3 North America Hereditary Cancer Testing Market, Revenues & Volume, By Single Site Genetic Test, 2021 - 2031 |
6.2 North America Hereditary Cancer Testing Market, Revenues & Volume, By Diagnosis Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Hereditary Cancer Testing Market, Revenues & Volume, By Biopsy, 2021 - 2031 |
6.2.3 North America Hereditary Cancer Testing Market, Revenues & Volume, By Imaging, 2021 - 2031 |
6.2.4 North America Hereditary Cancer Testing Market, Revenues & Volume, By Lab Tests, 2021 - 2031 |
6.3 North America Hereditary Cancer Testing Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Hereditary Cancer Testing Market, Revenues & Volume, By Sequencing, 2021 - 2031 |
6.3.3 North America Hereditary Cancer Testing Market, Revenues & Volume, By Polymerase Chain Reaction (PCR), 2021 - 2031 |
6.3.4 North America Hereditary Cancer Testing Market, Revenues & Volume, By Microarray, 2021 - 2031 |
6.4 North America Hereditary Cancer Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.2 North America Hereditary Cancer Testing Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 North America Hereditary Cancer Testing Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.4.4 North America Hereditary Cancer Testing Market, Revenues & Volume, By Laboratories, 2021 - 2031 |
6.4.5 North America Hereditary Cancer Testing Market, Revenues & Volume, By Radiology Centers, 2021 - 2031 |
6.4.6 North America Hereditary Cancer Testing Market, Revenues & Volume, By Diagnostic Centers, 2021 - 2031 |
6.4.7 North America Hereditary Cancer Testing Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 North America Hereditary Cancer Testing Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America Hereditary Cancer Testing Market, Revenues & Volume, By Direct Tender, 2021 - 2031 |
6.5.3 North America Hereditary Cancer Testing Market, Revenues & Volume, By Retail Sales, 2021 - 2031 |
7 North America Hereditary Cancer Testing Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Hereditary Cancer Testing Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.1 United States (US) Hereditary Cancer Testing Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.2 Canada Hereditary Cancer Testing Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.3 Rest of North America Hereditary Cancer Testing Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.3 North America Hereditary Cancer Testing Market Revenues & Volume Share, By Diagnosis Type, 2021 & 2031F |
7.3.1 United States (US) Hereditary Cancer Testing Market, Revenues & Volume, By Diagnosis Type, 2021 - 2031 |
7.3.2 Canada Hereditary Cancer Testing Market, Revenues & Volume, By Diagnosis Type, 2021 - 2031 |
7.3.3 Rest of North America Hereditary Cancer Testing Market, Revenues & Volume, By Diagnosis Type, 2021 - 2031 |
7.4 North America Hereditary Cancer Testing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.1 United States (US) Hereditary Cancer Testing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.2 Canada Hereditary Cancer Testing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.3 Rest of North America Hereditary Cancer Testing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5 North America Hereditary Cancer Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.1 United States (US) Hereditary Cancer Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.2 Canada Hereditary Cancer Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.3 Rest of North America Hereditary Cancer Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6 North America Hereditary Cancer Testing Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6.1 United States (US) Hereditary Cancer Testing Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6.2 Canada Hereditary Cancer Testing Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6.3 Rest of North America Hereditary Cancer Testing Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 North America Hereditary Cancer Testing Market Key Performance Indicators |
9 North America Hereditary Cancer Testing Market - Export/Import By Countries Assessment |
10 North America Hereditary Cancer Testing Market - Opportunity Assessment |
10.1 North America Hereditary Cancer Testing Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Hereditary Cancer Testing Market Opportunity Assessment, By Test Type, 2021 & 2031F |
10.3 North America Hereditary Cancer Testing Market Opportunity Assessment, By Diagnosis Type, 2021 & 2031F |
10.4 North America Hereditary Cancer Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.5 North America Hereditary Cancer Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10.6 North America Hereditary Cancer Testing Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
11 North America Hereditary Cancer Testing Market - Competitive Landscape |
11.1 North America Hereditary Cancer Testing Market Revenue Share, By Companies, 2022 |
11.2 North America Hereditary Cancer Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here